XRCC2 Gene Increases Breast Cancer Risk
Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics.
Read MoreMutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics.
Read MoreThe FDA has approved a new pre-analytical instrument that provides an integrated primary tube handling solution for Roches widely adopted automated molecular testing platform.
Read MoreA new study released by Geisinger Health System researchers hopes to identify better screening and treatment options for the condition.
Read MoreClinical and Laboratory Standards Institute announces the webinar “Verification of AST Methods for the Implementation of the Carbapenem and Cephalosporin Breakpoints.”
Read MoreThe two organizations established the only on-site hospital laboratory in the country utilizing the diagnostic technology called TEM-PCR.
Read More